carvedilol has been researched along with Cerebrovascular Disorders in 6 studies
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the effects of oral carvedilol (20 mg/day) on cerebral blood flow (CBF) and CBF autoregulation in ten previous stroke patients with hypertension." | 7.68 | Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension. ( Kuriyama, Y; Kyougoku, I; Nakamura, M; Sawada, T, 1990) |
| "Clinical guidelines suggest that for patients with heart failure and concurrent chronic obstructive pulmonary disease (COPD), metoprolol/bisoprolol/nebivolol should be preferred over carvedilol." | 3.91 | Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. ( Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM, 2019) |
| "In 102 patients with high risk (52 patients with history of myocardial infarction, 50 patients with history of cerebral stroke within previous 6-48 months) arterial hypertension (AH) we studied clinical efficacy on angiotensin converting enzyme inhibitor (ACEI) lisinopril, calcium antagonist felodipine, and nonselective - -blocker carvedilol in dependence on salt sensitivity of AH." | 3.76 | [Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt]. ( Babkin, AP; Gladkikh, VV; Gulaia, GI; Pershukov, IV, 2010) |
| "We studied the effects of oral carvedilol (20 mg/day) on cerebral blood flow (CBF) and CBF autoregulation in ten previous stroke patients with hypertension." | 3.68 | Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension. ( Kuriyama, Y; Kyougoku, I; Nakamura, M; Sawada, T, 1990) |
| "By subcutaneous insertion of osmotic minipumps leading to continuous infusion of l-adrenaline, we were able to induce hypertension in normotensive Wistar-Kyoto strain (WKY) rats which was shown to be completely reversible by application of the non-selective beta-adrenoceptor antagonist carvedilol." | 3.68 | Adrenaline in cardiovascular diseases--effect of beta-adrenoceptor antagonists. ( Dehner, R; Grobecker, H; Ikeda, K; Yamori, Y, 1990) |
| "Carvedilol treatment improved the impairment in the preparation from SHRSP." | 1.29 | Effects of chronic treatment with carvedilol on abnormalities of endothelium-dependent relaxation and structure of endothelium in resistance arteries of SHRSP. ( Hashimoto, H; Sasaki, F; Shibutani, T; Shimamura, K; Sunano, S; Tanaka, M; Yamamoto, K, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sessa, M | 1 |
| Mascolo, A | 1 |
| Rasmussen, DB | 1 |
| Kragholm, K | 1 |
| Jensen, MT | 1 |
| Sportiello, L | 1 |
| Rafaniello, C | 1 |
| Tari, GM | 1 |
| Pagliaro, C | 1 |
| Andersen, M | 1 |
| Rossi, F | 1 |
| Capuano, A | 1 |
| Babkin, AP | 1 |
| Gladkikh, VV | 1 |
| Pershukov, IV | 1 |
| Gulaia, GI | 1 |
| Yue, TL | 1 |
| Lysko, PG | 1 |
| Barone, FC | 1 |
| Gu, JL | 1 |
| Ruffolo, RR | 1 |
| Feuerstein, GZ | 1 |
| Sasaki, F | 1 |
| Yamamoto, K | 1 |
| Shimamura, K | 1 |
| Shibutani, T | 1 |
| Hashimoto, H | 1 |
| Tanaka, M | 1 |
| Sunano, S | 1 |
| Kuriyama, Y | 1 |
| Nakamura, M | 1 |
| Kyougoku, I | 1 |
| Sawada, T | 1 |
| Dehner, R | 1 |
| Ikeda, K | 1 |
| Yamori, Y | 1 |
| Grobecker, H | 1 |
1 review available for carvedilol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection.
Topics: Animals; Antihypertensive Agents; Antioxidants; Brain; Carbazoles; Carvedilol; Cerebrovascular Disor | 1994 |
5 other studies available for carvedilol and Cerebrovascular Disorders
| Article | Year |
|---|---|
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol | 2019 |
[Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Carvedil | 2010 |
Effects of chronic treatment with carvedilol on abnormalities of endothelium-dependent relaxation and structure of endothelium in resistance arteries of SHRSP.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Cerebro | 1995 |
Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Carbon Dioxide; Carvedilol; Cerebrovascular | 1990 |
Adrenaline in cardiovascular diseases--effect of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Cardiovascular Diseases; Carvedilo | 1990 |